水肿-话题@MedSci

#水肿#

227篇内容 | 4947人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1333313, encodeId=c3e31333313a6, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=Lancet Oncol：手术范围、超重或肥胖影响术后乳腺癌患者上臂淋巴水肿的发病率, objectType=article, longId=17164, objectId=5fec1e16400, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fec1e16400, replyNumber=0, likeNumber=62, createdTime=2013-04-13, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fec1e16400, moduleTitle=Lancet Oncol：手术范围、超重或肥胖影响术后乳腺癌患者上臂淋巴水肿的发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fec1e16400)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333312, encodeId=865c1333312fc, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=Diabetes Care:微动脉瘤更替预测临床意义黄斑水肿, objectType=article, longId=12939, objectId=38c41293999, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38c41293999, replyNumber=0, likeNumber=71, createdTime=2012-12-14, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38c41293999, moduleTitle=Diabetes Care:微动脉瘤更替预测临床意义黄斑水肿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38c41293999)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333311, encodeId=a92d133331113, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=SCI TRANSL MED：科学家在微型芯片模拟肺水肿, objectType=article, longId=11278, objectId=f0a1112e8bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0a1112e8bf, replyNumber=0, likeNumber=82, createdTime=2012-11-25, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0a1112e8bf, moduleTitle=SCI TRANSL MED：科学家在微型芯片模拟肺水肿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0a1112e8bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333310, encodeId=0b35133331099, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=JAMA：Cinryze用于遗传性血管性水肿有效时间长达2.6年, objectType=article, longId=9800, objectId=0f619800e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f619800e6, replyNumber=0, likeNumber=80, createdTime=2012-09-19, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f619800e6, moduleTitle=JAMA：Cinryze用于遗传性血管性水肿有效时间长达2.6年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f619800e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333309, encodeId=7e37133330966, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=BMJ:贝伐珠单抗和雷珠单抗治疗糖尿病黄斑水肿无显著性差异, objectType=article, longId=9014, objectId=b7e790149f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7e790149f, replyNumber=0, likeNumber=130, createdTime=2012-08-17, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7e790149f, moduleTitle=BMJ:贝伐珠单抗和雷珠单抗治疗糖尿病黄斑水肿无显著性差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7e790149f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333308, encodeId=037b13333084d, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=FDA推荐雷珠单抗治疗糖尿病黄斑水肿, objectType=article, longId=8616, objectId=88d586166c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88d586166c, replyNumber=0, likeNumber=67, createdTime=2012-08-08, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88d586166c, moduleTitle=FDA推荐雷珠单抗治疗糖尿病黄斑水肿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88d586166c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333307, encodeId=ab71133330e0e, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=糖尿病性黄斑水肿治疗新药Optina中期试验审查结束, objectType=article, longId=5755, objectId=0bd45e555c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bd45e555c, replyNumber=0, likeNumber=76, createdTime=2012-04-27, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bd45e555c, moduleTitle=糖尿病性黄斑水肿治疗新药Optina中期试验审查结束, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bd45e555c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333306, encodeId=c8521333306bc, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=Ophthalmology：兰尼单抗治疗黄斑水肿不能快速起效, objectType=article, longId=4125, objectId=cd564125ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd564125ba, replyNumber=0, likeNumber=75, createdTime=2012-02-26, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd564125ba, moduleTitle=Ophthalmology：兰尼单抗治疗黄斑水肿不能快速起效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd564125ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1333305, encodeId=938a13333058b, content=<a href='/topic/show?id=4ce26423802' target=_blank style='color:#2F92EE;'>#水肿#</a>, objectTitle=FDA批准艾替班特(Firazyr)治疗遗传性血管性水肿(HAE)急性发作, objectType=article, longId=3148, objectId=b2e131484c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2e131484c, replyNumber=0, likeNumber=69, createdTime=2011-10-11, rootId=0, userName=小华子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2e131484c, moduleTitle=FDA批准艾替班特(Firazyr)治疗遗传性血管性水肿(HAE)急性发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2e131484c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

水肿

2020-05-29

小华子 (审核中...)

前往app查看评论内容

#水肿#

Lancet Oncol：手术范围、超重或肥胖影响术后乳腺癌患者上臂淋巴水肿的发病率

2013-04-13

小华子 (审核中...)

前往app查看评论内容

#水肿#

Diabetes Care:微动脉瘤更替预测临床意义黄斑水肿

2012-12-14

小华子 (审核中...)

前往app查看评论内容

#水肿#

SCI TRANSL MED：科学家在微型芯片模拟肺水肿

2012-11-25

小华子 (审核中...)

前往app查看评论内容

#水肿#

JAMA：Cinryze用于遗传性血管性水肿有效时间长达2.6年

2012-09-19

小华子 (审核中...)

前往app查看评论内容

#水肿#

BMJ:贝伐珠单抗和雷珠单抗治疗糖尿病黄斑水肿无显著性差异

2012-08-17

小华子 (审核中...)

前往app查看评论内容

#水肿#

FDA推荐雷珠单抗治疗糖尿病黄斑水肿

2012-08-08

小华子 (审核中...)

前往app查看评论内容

#水肿#

糖尿病性黄斑水肿治疗新药Optina中期试验审查结束

2012-04-27

小华子 (审核中...)

前往app查看评论内容

#水肿#

Ophthalmology：兰尼单抗治疗黄斑水肿不能快速起效

2012-02-26

小华子 (审核中...)

前往app查看评论内容

#水肿#

FDA批准艾替班特(Firazyr)治疗遗传性血管性水肿(HAE)急性发作

2011-10-11

科室
- - 订阅+
  - 更多科室
工具
服务